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CRISPR-induced double-strand breaks trigger
recombination between homologous chromosome arms
Erich Brunner1,* , Ryohei Yagi2,* , Marc Debrunner1 , Dezirae Beck-Schneider1, Alexa Burger1, Eliane Escher1,
Christian Mosimann1, George Hausmann1, Konrad Basler1
CRISPR–Cas9–based genome editing has transformed the life sci-
ences, enabling virtually unlimited genetic manipulation of genomes:
The RNA-guided Cas9 endonuclease cuts DNA at a speciﬁc target se-
quence and the resulting double-strand breaks are mended by one of
the intrinsic cellular repair pathways. Imprecise double-strand repair
will introduce random mutations such as indels or point mutations,
whereas precise editing will restore or speciﬁcally edit the locus as
mandated by an endogenous or exogenously provided template.
Recent studies indicate that CRISPR-induced DNA cuts may also result
in the exchange of genetic information between homologous chro-
mosomearms. However, conclusive data of such recombination events
in higher eukaryotes are lacking. Here, we show that in Drosophila, the
detected Cas9-mediated editing events frequently resulted in
germline-transmitted exchange of chromosome arms—often with-
out indels. These ﬁndings demonstrate the feasibility of using the
system for generating recombinants and also highlight an un-
foreseen risk of using CRISPR-Cas9 for therapeutic intervention.
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Introduction
CRISPR–Cas9–based genome editing has revolutionized genetic
research, triggering the development of a plethora of technologies
and applications that provide unprecedented control over genes in a
growing list of model species (1, 2, 3, 4, 5, 6, 7, 8). CRISPR systems allow
us to edit, engineer, or regulate genomes, hold great promise for
clinical applications, and are likely to be used to treat diseases with
genetic underpinnings, including cancer (9, 10). Genome editing is
achieved by precisely targeting the nuclease activity of a modiﬁed
bacterial protein (Cas9) via a user-deﬁned guide RNA to a speciﬁc
DNA sequence (1). The resulting DNA double-strandbreaks (DSBs) are
repaired either by the error-prone nonhomologous end joining
(NHEJ) or homology-directed repair (11). For reﬁned and precise
genome editing purposes, homology-directed repair is harnessed to
copy a speciﬁc DNA template (single-stranded or double-stranded)
into the target site (2, 9, 12, 13). In contrast, NHEJ ligates the two broken
ends of the DNA without a donor template, often resulting in random
insertions or deletions (indels) that can disrupt coding sequences at
the target site (for review see reference 14). However, with directly
ligateable ends, NHEJ may lead to accurate repair of close and
concurrent DSBs (15, 16, 17, 18), also when induced by Cas9 (19, 20, 21,
22). The ability of CRISPR–Cas9 to introduce several concurrent DSBs
at deﬁned positions has enabled engineering of tumor-associated
chromosomal translocations resembling those observed in cancers,
and hence to establish and test novel in vitro and in vivo tumor
models (2, 23, 24, 25). Sadhu et al. (26) leveraged the CRISPR–Cas9
system to produce other chromosomal rearrangements, generating
targeted mitotic recombination events in yeast to enable the ﬁne
mapping of trait variants. The authors deliberately induced a single
DSB in one of the homologous chromosomes in a diploid yeast strain
and achieved homologous recombination-based “loss of heterozy-
gosity” events within 20 kb of the target site. Additional reports
suggest that recombination in mitotic cells is not restricted to yeast
but may also occur in other species such as houseﬂies (27) and
tomatoes (28). What is currently missing is a solid conﬁrmation of
such events and data on their frequency in different species.
Here, we set out to examine the occurrence and frequency of
genetic exchanges between homologous chromosome arms initi-
ated by Cas9-induced DSBs. We show that Cas9-triggered DSBs
induce germline-transmitted recombination between homologous
chromosome arms in up to 39% of the CRISPR events in Drosophila.
Although these ﬁndings expand the tool-box of CRISPR-based
genome manipulation in research, they also raise concerns about
the use of gene editing in therapeutic settings.
Results
CRISPR/Cas9 cuts induce recombination events
NHEJ is a major repair mechanism triggered by CRISPR–Cas9–
induced DSBs inDrosophila (29, 30). Leveraging on this, we developed
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a system for activating transgene expression through NHEJ-based
repair. The system, which we named CIGAR (CRISPR-Induced Gene
Activator), allows activation of transgene expression after CRISPR-
induced DSBs. The principle of the CIGAR system is based on acti-
vation of gene expression if, and only if, a unique CRISPR–Cas9 target
sequence has been cleaved and rearranged by NHEJ (Fig 1). CIGAR
consists of four elements: (i) the ubiquitin-p63E promoter to drive
gene expression in every cell (31), (ii) a so-called “shifter” sequence,
(iii) a ﬂexible linker sequence inserted 39 of the shifter sequence (32),
and (iv) a reporter cDNA (lacking a translational start codon) followed
by the 39UTR of theDrosophila tubulin α1 gene. The functional core of
the CIGAR reporter lies within the shifter sequence, which contains
optimized translational START codons covering all three frames
upstream of a unique 20-nt CRISPR target sequence (33, 34). Each
initiation codon is blocked downstream by a corresponding in-frame
STOP codon. Importantly, the most 59 STOP codon, named STOPT (T
for target), is in-frame with the downstream ORF and resides within
the unique 20-nt gRNA target, starting 4 nt upstream of the PAM
sequence. Activation of CIGAR is achieved by Cas9-induced DNA
cleavage within the STOPT codon. The induced DSBs will then be
mended by NHEJ-mediated repair concomitantly severing or elimi-
nating the STOPT codon. The resulting indel leads to repositioning of
the upstream ATGs relative to theORF, that is, causing one of the ATGs
to be “shifted in-frame” with the ORF.
Two variants of this CIGAR tool box, that is, CIGAReGFP or
CIGARmCherry are depicted in Figs 1 and 2A. Further details of the CIGAR
system will be submitted elsewhere. When we molecularly analyzed
the shifter sequences in the progeny of females carrying the two
CIGAR transgenes in trans (genotype: nos-Cas9, CIGAReGFP/CIGARmCherry;
U6:3-sgRNACIGAR(1,2)/+), we found that in some of the F1 animals, the
CRISPR target sequence of the CIGARmCherry reporter became located
59 of the eGFP ORF and vice versa. Sequence analysis of 84 animals
from different crosses revealed a total of 26 animals in which the
sequences on one side of the DSB had been exchanged (Figs 2B, S1,
and S2 and Table S1). The site of the DSBwas in partmarked by indels.
From these results, we concluded that in these animals, re-
combination events had occurred at the site of the Cas9-induced
DSBs. We would like to emphasize that the term recombination is
used here to describe the exchange of genetic material between
homologous chromosome arms initiated by CRISPR-induced DSBs.
Because Cas9 activity may often cause the break of both homologs,
such recombination events may not only be based on homologous
recombination but may also result by breakage/fusion events in-
volving NHEJ that lead to a crosswise ligation of the chromosome
arms (15, 16, 17, 18, 19, 20, 21, 22). From our results, however, we cannot
infer which repair mechanism was involved in the exchange of ge-
netic information between homologous chromosome arms.
In the experiment described above, the CIGAR transgenes were
located at position 5D on the X-chromosome that shows native
recombination activity in the female germline (35). To further test if
CRISPR–Cas9 could induce efﬁcient site-speciﬁc recombination, we
turned to the fourth chromosome for which normally no naturally
occurring recombination is observed (36, 37, 38). We ﬁrst generated
transgenic animals harboring the CIGAReGFP and CIGARmCherry
construct at position 102F on the two homologous arms of chro-
mosome 4, in addition to nos-Cas9 and U6:3-sgRNACIGAR(1,2). Such
Figure 1. CIGAR design and activation.
(A) CIGAR consists of four elements: 1. Ubiquitin-p63E
promoter (brown box), 2. “shifter” sequence, 3. linker
sequence (orange), 4. reporter cDNA (ORF) lacking a
translational start site followed by the tubulin 39UTR
(grey open arrow). The shifter sequence contains
optimized translation initiation codons covering all
three frames (light blue boxes) and a guide RNA target
region (purple box) followed by a protospacer adjacent
motif (PAM) (black box). In the inactive CIGAR,
translation from each ATG (grey arrows) is terminated 59
of the ORF by a STOP codon (red asterisks) preventing
the translation of the downstream ORF. (B) Activation of
two CIGAR variants harboring either an eGFP or a
monomeric Cherry (mCherry). Activation is achieved by
Cas9-induced DNA cleavage within stopT (pink), the
most upstream STOP codon which is in-frame with the
downstream ORF. The resulting double-strand break
(DSB; the putative site of the DSB, 3 bp upstream of the
PAM site is indicated with a pink, open arrowhead) is
mended by NHEJ-mediated repair concomitantly
eliminating stopT (indel; open white box) and shifting
one of the ATGs in-frame with the ORF. Flies that
inherited a translationally activated CIGAR appear
uniformly green or red. The eye-speciﬁc red
ﬂuorescence marks the attP target site into which the
CIGAR constructs have been inserted. (C) Comparison of
the 20-nt sgRNA target sequences of CIGAReGFP and
CIGARmCherry, respectively. The 9-bp substitutions in the
two target sites are indicated. (D) For speciﬁc and
simultaneous targeting of both reporters, a tRNA-
spaced tandem array (U6:3-sgRNACIGAR(1,2) harboring
sgRNA-1 (targeting CIGAReGFP) and sgRNA-2 (targeting
CIGARmCherry) is used.
CRISPR–Cas9–induced recombination Brunner et al. https://doi.org/10.26508/lsa.201800267 vol 2 | no 3 | e201800267 2 of 11
individuals were crossed to yw animals, and their offspring were
scored for recombination events (Fig 2C, see the Materials and
Methods section for details). Animals were randomly picked from 13
crosses immediately after hatching and analyzed for the sequences
ﬂanking the target site (Tables S2 and S3). This revealed that in 41 of
156 animals, recombination events had occurred (Fig 2B; for details
see the Materials and Methods section). Thus, as described above
for the X chromosome, numerous CRISPR-mediated recombination
events were observed on the fourth chromosome (39% of the
detected Cas9-triggered events, i.e., 41 of 105 CRISPR events).
CRISPR-induced recombination between two distant phenotypic
markers
In the above experiments, recombination was induced between
homologous chromosome arms for which the nt at the Cas9 target
site as well as the ﬂanking sequences (coding for the ﬂuorescent
proteins) differed. However, the recombination events could only
be demonstrated by sequence analysis of the immediate vicinity of
the CRISPR site; more distant phenotypic markers were not present
on these chromosomes. Therefore, we could not rule out that, at
least in some cases, other mechanisms, such as gene conversion,
were responsible for the observed sequence exchange between the
two CIGAR reporters in trans (39).
To conﬁrm that indeed a complete exchange of the homologous
chromosome arms occurs distal to the CRISPR–Cas9–induced DSBs,
we used two visible markers separated by more than 100 kb (Figs 3A
and S3): the w+-marked CIGARmCherry,102F, w+ and the recessive viable
mutation svspa-pol close to the tip of the right arm on chromosome 4.
We selected the Cas9 target site, targeted with sgRNA-3, in the 39UTR of
the toy gene residing about 18 kb downstream of the CIGARmCherry,102F, w+
transgene insertion site. To induce recombination at the target site (Fig
3A, TR; see the Materials and Methods section for more experimental
details), we injected yw; CIGARmCherry,102F,w+/Dp(1;4)1021,y+, svspa-pol
embryos with active Cas9-sgRNA RNP complexes containing
recombinant Cas9 and in vitro–translated sgRNA-3 (Fig 3B) (40, 41). G0
Figure 2. Detailed CIGAReGFP and CIGARmCherry reporter
design and illustration of recombination events on the
sequence level.
(A) Design and sequence details of un-CRISPRed
CIGAReGFP (top) and CIGARmCherry reporters (bottom). The
sequences of the sgRNAs and the ORFs are shaded in
green and red, respectively. Note that except for the
sgRNAs and the ORFs, the sequences of the reporters are
identical. The targeted STOP codon (stopT; pink) differ in
sequence. The CRISPR target sites are delineated in the
sequence context (pink, open arrows). Analysis of the
shifter sequence is performed using primer pairs speciﬁc
for the Ubi promoter and the 59 end of the respective ORF
(purple arrows). (B) The shifter region of ﬂies harboring a
single copy of one of the CIGAR reporters on the X
chromosome (attP 5D) was analyzed by single ﬂy PCR and
Sanger sequencing. Shown are recombination events
from a CIGAReGFP/CIGARmCherry co-targeting experiment
visualized on the sequence level. As in (A), the sequences
of the sgRNAs and the ORFs are shaded in green and red,
respectively. Recombinants exhibit a rearranged
sequential arrangement (green-red or red-green) of
sgRNA and reporter cDNA. Note that recombination
events may or may not be accompanied by indels at the
target site. (C) Co-targeting experiments using CIGAR
reporters on the fourth chromosome (attP 102F). 172
animals were analyzed by single ﬂy PCR and Sanger
sequencing. The yellow sections represent the number of
recombinants with or without indel.
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animals were crossed with homozygous yw;Dp(1;4)1021,y+, svspa-pol ﬂies
to visually detect recombination events in the offspring (i.e., the two
visible markers co-segregate upon recombination; see Fig 3B and C
and see the Materials and Methods section for details). From 8,604
offspring, we recovered 253 putative recombinants (Fig 3D). Of these
253 animals, we further characterized 57 deriving mostly from in-
dependent crosses. 21 of the 57 animals turned out to be true
germline-transmitted recombinants that were homozygous viable (TR-
A and TR-B in Fig 3E and Tables S4 and S5). Molecular analysis of the
Cas9 target site revealed that 19 of these 21 recombinants did not
contain an indel lesion at the CRISPR site (sequence traces with
indels are shown in Table S4). Extrapolating from the 21 conﬁrmed
recombinants (out of 57) to the 253 putative recombinants (out of
8,604 F1 animals), the frequency of CRISPR-mediated targeted re-
combination in this experiment is estimated to be ~1.1%. This frequency
is at least four orders of magnitude higher than that of the rare
spontaneous recombination rate predicted for chromosome 4 (37).
CRISPR-induced DSBsmay lead to loss of chromosomal structures
The remaining 36 (out of 57) putative recombinants recovered from
the above experiment were homozygous lethal and exhibited position
effect variegation (PEV; Fig 4A and B) in the adult compound eye. PEV
in the eye occurs if the mini-white gene (w+), used as transgene
reporter, is juxtaposed to heterochromatic regions via chromosomal
rearrangements or translocations (42, 43, 44, 45). In particular, the
proximity of the mini-white gene to the heterochromatic telomere
regions may lead to PEV (46). We, therefore, reasoned that in animals
showing PEV, the Cas9-based editing led to a loss of chromosome
structures distal to the DSB and consequently, expression of themini-
white gene of the CIGAR transgene is variably silenced. Similar events
have been reported for X-ray–induced DSBs on the fourth chromo-
some (47). To assess the presence or absence of themost distal part of
the chromosomes showing PEV, we tested CIGARmCherry,102F,w+/ chro-
mosomes for complementation of the lethal svΔ122 null mutation.
Independently recovered yw; CIGARmCherry,102F,w+,PEV/Dp(1;4)1021,y+,
svspa-pol animals exhibiting PEV were crossed to yw; ciD,svspa-pol/svΔ122
animals. Without exception, the tested PEV chromosomes were un-
able to complement the svΔ122 mutation, indicating that they must
have lost distal parts of chromosome 4.
Recombination is triggered by, and conﬁned to the site of,
Cas9-induced DSBs
Finally, to exclude that Cas9-induced DSBs merely stimulate
nonspeciﬁc recombination (NSR) on the fourth chromosome (i.e.,
Figure 3. Cas9-induced recombination between two
phenotypic markers on the fourth chromosome.
(A) Each of the twomarkers (w+ [mini-white] and svspa-pol) is
located on a different homologous chromosome. The
two markers are separated by about 100 kb. The svspa-pol
chromosome is marked with y+ due to a duplication of X-
chromosomal material to the short, left arm of
chromosome four. The Cas9 cut site is represented by a
red dashed line and red open arrow heads. The repair of
CRISPR-induced DSB may lead to targeted
recombination events (TR) between the two markers.
(B) Embryos with the genotype yw; CIGARmCherry,102F,w+/
Dp(1;4)1021,y+, svspa-pol were injected with recombinant
Cas9 RNPs containing in vitro–translated sgRNA-3. (C)
Cas9 RNP injected G0 animals are backcrossed to
animals with the genotype yw; Dp(1;4)1021,y+, svspa-pol/
Dp(1;4)1021,y+, svspa-pol to be able to visually score
putative recombinants. The phenotype of the animals is
shown. (D) A total of 8,604 animals were screened and
253 putative recombinants were recovered. (E)
Unrecombined animals (UR) appeared phenotypically
as y+; w+ (UR-A) or y+; svspa-pol (UR-B). Putative
recombinants (boxed) presented either as y+; w+;
svspa-pol (TR-A) or y+, sv+ animals (TR-B).
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not at the Cas9 target site), we repeated the experiment using the
same experimental conditions, but assessed recombination be-
tween a y+ marker on the short left arm of chromosome 4 and the
w+-marked CIGARmCherry,102F transgene inserted at 102F of the right
arm (Fig 4C–E, NSR; see the Materials and Methods section for more
experimental details). Embryos of the genotype yw; CIGARmCherry,102F, w+/
Dp(1;4)1021, y+, svspa-pol were injected with RNPs containing Cas9
protein complexed with in vitro–translated sgRNA-3. The RNPs in-
duce DSBs 39 of toy located distal of CIGARmCherry,102F but should not
have any inﬂuence on the recombination between the y+ and the w+
markers. G0 animals were crossed with yw animals to score re-
combination events between the y+ and the w+ marker (Fig 4D). We
screened more than 13,000 F1 animals but did not observe a single
recombination event between the markers (NSR-A or NSR-B in Fig 4E,
see the Materials and Methods section for details). These results are
consistent with the notion that no spontaneous recombination
occurs between the fourth chromosomes and that the re-
combination observed in the previous experiments above (Fig 3, TR)
were triggered by, and conﬁned to the site of, CRISPR-induced DSBs.
In summary, our experiments involving chromosome 4 revealed
that germ-line–transmitted recombinants can be recovered at
frequencies ranging from about 1.1% (recombination between
visible markers) to 26% (recombination between CIGAR constructs;
see the Materials and Methods section). These percentages rep-
resent the number of recombinants recovered from the total
number of animals analyzed. When only the detected Cas9-
mediated events are taken into consideration, the frequency of
recombination was even 39%.
Discussion
Our results show that a substantial amount of CRISPR–Cas9–
induced DSBs result in exchanges between homologous chromo-
some arms. Importantly, the recombination events we see occur in
multiple experimental settings and not only under speciﬁc con-
ditions. In this context, it is important to point out that re-
combination events observed in experiments where Cas9 has been
provided as recombinant protein exclusively occurred in mitotic
and not in meiotic cells: a study by Burger and colleagues shows
that ﬂuorescently labeled Cas9 RNP complexes are detectable until
about 18 h after injection (40). In Drosophila, however, the ﬁrst
meiotic divisions occur at much later timepoints (i.e., in males in the
Figure 4. CRISPR-induced DSBs may lead to loss of
chromosomal structures.
(A)Of the putative 257 recombinants (see Fig 3D), 57 were
characterized in more detail. 21 were true recombinants,
whereas 36 animals had a loss of chromosomal
structures distal to the CRISPR target site which
manifested in PEV, that is, variable expression of the
mini-white gene. (B) Fly exhibiting PEV is shown. The
genotype of the ﬂy and the loss of chromosomal
structures distal to the cut site are shown below the
image. Important to note is that only the loss of distal
chromosome structures of the w+ chromosome can be
scored from the TR screen (described in Fig 3). The
corresponding loss of svspa-pol on the Dp(1;4)1021,y+
chromosome is phenotypically identical to UR-B (Fig 3E)
and will not be recovered from the screen. (C) Control
experiment to assess if CRISPR–Cas9–induced DSBs in
general enhances the frequency of recombination away
from the Cas9 cut site (dashed line and red open
arrowheads). (D) Cas9 RNP–injected animals (same as in
Fig 3B) are backcrossed to animals with the genotype yw
to be able to visually score NSR events between w+ and
y+. (E) No NSR between y+ and w+ marker (NSR-A and
NSR-B) were recovered amongst 13,220 animals
screened (see text and the Materials and Methods
section for more details).
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third instar larvae, about 3–4 d after injection and in females at
early pupal stages (48)), likely excluding residual activity of Cas9
RNPs.
In experiments where Cas9 protein and the sgRNAs are provided
via transgenes (49, 50), Cas9 expression is driven by the nanos (nos)
promoter and the Cas9 transgene contains the nos 39UTR re-
capitulating germline-speciﬁc nos expression, transcript localization,
and translational control (49, 51, 52). Hence, Cas9 is maternally
provided to the offspring and likely not expressed zygotically during
embryogenesis (53). In females, Nos is available during mitotic di-
visions in the germline stem cells as well as in those that later on
form the 16-cell cyst in the germline. It should not be present in the
growing oocytewheremeiosis would occur (53). In themale germline,
nos expression seems to be essential during spermatogenesis (54).
Loss of nos expression leads to various phenotypes with strongest
effects on the number of primary spermatocytes that are created
through mitotic divisions. Together, these arguments suggest that
also in case the CRISPR reagents are provided via transgenes, re-
combination events occurred preferentially in mitotic cells. However,
because the nos-Cas9 transgene is not inserted into the nos locus,
presence of Cas9 protein and extension recombination events in
meiotic cells cannot strictly be ruled out.
One reason why CRISPR-induced recombination has largely
remained unnoticed in genetic model organisms is that DSBs are
frequently repaired without resulting indels and thus cannot be
detected by next-generation sequencing, preventing any follow-up
validation of broader effects. When detected using genetic and
sequencing validation, we noted variable recombination rates in
our experiments. We attribute this variability to three experimental
aspects. First, the different Cas9 target sites may have different
cutting and recombination efﬁcacy (30, 55). Second, individual
crosses may yield different numbers of progeny harboring CRISPR-
derived indels (i.e., CRISPRed (G0) animals transmit a variable
number of mutant alleles to the next generation, ranging from 0 to
100% as shown for the recovery of a nonfunctional y allele, see Fig 2
in reference 49). Third, in our experiments, different methods were
used to introduce Cas9 and gRNAs, a circumstance that likely con-
tributed to the different frequencies of recombinants recovered (49).
The Cas9-mediated site-speciﬁc chromosomal recombination
described here opens up a number of new avenues and con-
siderations for genome engineering. We demonstrate that in
Drosophila, Cas9-mediated DSBs can be used to generate re-
combination at a predeﬁned site between chromosomal loca-
tions that are in close vicinity. Unlike for site-speciﬁc recombination
based on Flp (56, 57), no recombinase target sites need to be
present. Thus, CRISPR-mediated site-speciﬁc recombination en-
ables the combination of two knownmutations situated in different
alleles of one and the same gene into a single (double-)mutant
allele. Moreover, it could be used to study permutations of mutant
alleles in tightly linked genes such as members of a Hox gene
cluster (58). Especially in vertebrates, such as mouse or zebraﬁsh,
CRISPR-induced recombination holds promise for a number of
applications, including generation of complex mutant alleles in the
same locus (59). Also, in Drosophila, Cas9-mediated recombination
enables experiments that were previously impossible because of
low or absent recombination rates. For example, by providing
sgRNAs or Cas9 activity in a tissue-speciﬁc manner, it may become
possible to generate speciﬁc mutant clones for genes located on
the fourth chromosome. Finally, targeted Cas9-mediated re-
combination could potentially be used in epigenetic studies to
determine the effects of swapping promoters, including their
epigenetic marks, between maternal and paternal genes.
On the other hand, our ﬁndings that recombination between
homologous chromosome arms may be triggered upon Cas9-
induced DSBs underscore the need for caution in applying
CRISPR-based genetic interventions in animals or humans (60):
Unrecognized CRISPR-induced recombination events (i.e., no visible
indels at the target site) may lead to loss-of-heterozygosity events,
generating cells with unnoticed homozygosity for imprinted genes
or recessive mutations located distal to the Cas9 target site, which
may have unforeseen consequences.
Moreover, we observed that CRISPR-based engineering can lead to
loss of chromosome material distal to the locus of the DSB (Fig 4B).
We could observe such events in our system because haplo-four
animals (harboring only a single copy of the fourth chromosome) are
viable (61). Under most circumstances, and likely in most organisms,
such events would lead to the death of the affected cells because of
haploinsufﬁciency. In this context, recent work suggested that Cas9
induces mutations in human cells and mice that are larger than
anticipated (62). Therefore, it is imperative to routinely consider
broader chromosomal alternations as possible outcome when ap-
plying CRISPR technologies in translational medicine.
Materials and Methods
Plasmid construction
Unless otherwise noted, the plasmids were constructed by stan-
dard molecular cloning methods. When plasmids contain newly
synthesized nt sequences via PCR, oligonucleotide synthesis, or
mutagenesis, the sequences were veriﬁed by DNA sequencing.
pUbiattB
The StuI-ubiquitin p63E promoter (ubi)-EcoRI fragment from
pCaSpR3-Up2-RX polyA was subcloned into a pBluescript (pBS)
vector between the EcoRI and XhoI sites using blunt-end ligation.
The EcoRI-ubi-Acc65I fragment from the resulting plasmid was
subcloned into pEPattB (63) using the EcoRI and Acc65I sites.
pUbiattB-CIGAReGFP
To create the pUbiattB-CIGAReGFP reporter, the shifter sequence
(containing optimized translational START codons covering all
three frames upstream of a unique 20-nt CRISPR target sequence), a
unique gRNA target sequence (referred to as sgRNA-1), the linker
sequence, and the eGFP gene were designed (as shown below),
synthesized by GenScript, and delivered ligated into the pUC57-Kan
vector (pCIGAR-D0).
The pCIGAR-D0 insert:
59-KpnI_CAACATGGTGCAACATGGTGCAACATGGTGCGGCGACAGCAGA
ACGTAGCGGGACGATAGGCTGCAGATCCTTGGCGCGCCTTCAGGAGGCGGT-
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GCTACTGCTGGCGCTGGTGGAGCCGGTGGACCTGCGGGGTTAATTGTGAGC-
AAGGGCGAGGAGCTGTTCACCGGGGTGGTGCCCATCCTGGTCGAGCTGGAC-
GGCGACGTAAACGGCCATAAGTTCAGCGTGTCCGGCGAGGGCGAGGGCGA-
TGCCACCTACGGCAAGCTGACCCTGAAGTTCATCTGCACCACCGGCAAGC-
TGCCCGTGCCCTGGCCCACCCTCGTGACCACCCTGACCTACGGCGTGCAGT-
GCTTCAGCCGCTACCCCGACCACATGAAGCAGCACGACTTCTTCAAGTCCGC-
CATGCCCGAAGGCTACGTCCAGGAGCGCACCATCTTCTTCAAGGACGACGG-
CAACTACAAGACCCGCGCCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAA-
CCGCATCGAGCTGAAGGGCATCGACTTCAAGGAGGACGGCAACATCCTG-
GGGCACAAGCTGGAGTACAACTACAACAGCCACAACGTCTATATCATGGCC-
GACAAGCAGAAGAACGGCATCAAGGTGAACTTCAAGATCCGCCACAACATC-
GAGGACGGCAGCGTGCAGCTCGCCGACCACTACCAGCAGAACACCCCCATC-
GGCGACGGCCCCGTGCTGCTGCCCGACAACCACTACCTGAGCACCCAGTC-
CGCCCTGAGCAAAGACCCCAACGAGAAGCGCGATCACATGGTCCTGCTG-
GAGTTCGTGACCGCCGCCGGGATCACTCTCGGCATGGACGAGCTGTACAAG-
TAAGAATTC_EcoRI-39.
The synthetic sequence was excised with KpnI and EcoRI and
ligated into pre–double-digested pKB342 vector in line with a tu-
bulin 39 trailer, transformed, and puriﬁed, resulting in pKB342_CI-
GAR. To remove the CIGAR sequence including the tubulin trailer,
pKB342_CIGAR was then digested with KpnI and XbaI, and the
fragment was ligated into a KpnI- and XbaI-digested pUbiattB
vector containing an ubiquitin-p63E promoter (see above). This
resulted in the ﬁnal product referred to as pUbiattB-CIGAReGFP.
pUbiattB-CIGARmCherry
The same sequential digestions and ligation as for the making of the
pUbiattB-CIGAReGFP were used for the construction of the pUbiattB-
CIGARmCherry. The only difference was in the design of the target site;
the gRNA (sgRNA-2) has a different unique target sequence and
contains the mCherry gene as the ﬂuorescent marker. The insert
ligated into the pUC57-Kan vector was ordered from GenScript.
The CIGARmCherry insert:
59-KpnI_CAACATGGTGCAACATGGTGCAACATGGTGCCCCGAGACAAGC-
ACCTGACGGGACGATAGGCTGCAGATCCTTGGCGCGCCTTCAGGAGGCGGT-
GCTACTGCTGGCGCTGGTGGAGCCGGTGGACCTGCGGGGTTAATTGTGAG-
CAAGGGCGAGGAGGACAACATGGCCATCATCAAGGAGTTCATGCGCTTTAA-
GGTGCACATGGAGGGCTCCGTGAACGGCCACGAGTTCGAGATCGAGGGC-
GAGGGCGAGGGCCGCCCCTACGAGGGCACCCAGACCGCCAAGCTGAAGG-
TGACCAAGGGCGGCCCCCTGCCCTTCGCCTGGGACATCCTGTCCCCTCAGTT-
CATGTACGGCTCCAAGGCCTACGTGAAGCACCCCGCCGACATCCCCGACTAC-
TTGAAGCTGTCCTTCCCCGAGGGCTTCAAGTGGGAGCGCGTGATGAACTTCG-
AGGACGGCGGCGTGGTGACCGTGACCCAGGACTCCTCCCTGCAGGACGGCG-
AGTTCATCTACAAGGTGAAGCTGCGCGGCACCAACTTCCCCTCCGACGGCCC-
CGTAATGCAGAAGAAGACCATGGGCTGGGAGGCCTCCTCCGAGCGGATGTA-
CCCCGAGGACGGCGCCCTGAAGGGCGAGATCAAGCAGAGGCTGAAGCTGAA-
GGACGGCGGCCACTACGACGCCGAGGTCAAGACCACCTACAAGGCCAAGAA-
GCCCGTGCAGCTGCCCGGCGCCTACAACGTCAACATCAAGCTGGACATCACC-
TCCCACAACGAGGACTACACCATCGTGGAACAGTACGAGCGCGCCGAGGGC-
CGCCACTCCACCGGCGGCATGGACGAGCTGTACAAGTAA_EcoRI-39.
U6:3-sgRNACIGAR(1,2) (pCFD5-F1)
The pCFD5 vector was a gift from Fillip Port (#73914; Addgene) (50).
pCFD5 is the main backbone containing the tRNA assembly pre-
pared to insert multiple gRNAs. For our purposes, sgRNA-1 and
sgRNA-2 were inserted via Gibson cloning into the pCFD5 vector
(named pCFD5-F1) following the protocol described in the sup-
plementary methods of pCFD5 cloning protocol.
pCFD5 internal tRNA multi-gRNA Scaffold:
59-GTCGGGGCTTTGAGTGTGTGTAGACATCAAGCATCGGTGGTTCAGTGG-
TAGAATGCTCGCCTGCCACGCGGGCGGCCCGGGTTCGATTCCCGGCCGATG-
CAGGGTCTTCGTTTTAGAGCTAGAAATAGCAAGTTAAAATAAGGCTAGTCCGT-
TATCAACTTGAAAAAGTGGCACCGAGTCGGTGCAACAAAGCACCAGTGGTC-
TAGTGGTAGAATAGTACCCTGCCACGGTACAGACCCGGGTTCGATTC-
CCGGCTGGTGCAGAAGACCTGTTTTAGAGCTAGAAATAGCAAGTTAAAATAAG-
GCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCGGTGCTTTTTT-39.
Through the process of Gibson cloning, both our sgRNA-1 and
sgRNA-2 were inserted into the pCFD5 vector using primer (59-
GCGGCCCGGGTTCGATTCCCGGCCGATGCACGGCGACAGCAGAACGTA-
GCGTTTTAGAGCTAGAAATAGCAAG-39) for sgRNA-1 and (59-ATTT-
TAACTTGCTATTTCTAGCTCTAAAACGTCAGGTGCTTGTCTCGGGGTGCAC-
CAGCCGGGAATCGAACCC-39) for sgRNA-2.
IVT of sgRNA-3
IVT of sgRNAs were performed as described in reference 40. For IVT,
we used MEGAscript (AM1334), and for the puriﬁcation of the IVT
products, we used Puriﬁcation: MEGAclear (AM1908).
IVT oligo used speciﬁc for sgRNA-3:
59-GAAATTAATACGACTCACTATAGGCTGTTGATAAGCACGCAATCGTTT-
TAGAGCTAGAAATAGC-39.
IVT oligo used sgRNA-R used for template PCR:
59-AAAAGCACCGACTCGGTGCCACTTTTTCAAGTTGATAACGGACTAGCC-
TTATTTTAACTTGCTATTTCTAGCTCTAAAAC-39.
Complementary sequences of the speciﬁc sgRNA primer and the
sgRNA-R are shown in bold letters.
Cas9/sgRNA RNP injections
The concentration of SpCas9 injected was about 800 ng/μl SpCas9
(ﬁnal concentration) and about 300 ng/μl of sgRNA (IVT; ﬁnal
concentration after puriﬁcation). This corresponds roughly to a 1:2
ratio (SpCas9: sgRNA-3). SpCas9 has about 5× the molecular weight
of the sgRNA.
The injection mix is prepared as follows (total volume of 10 μl):
add sgRNA, ddH2O, and 10× incubation buffer NEB and mix thor-
oughly. Gently add the SpCas9 and mix again thoroughly by
pipetting up and down. It is mandatory to add SpCas9 as the last
ingredient because low salt concentrations may cause SpCas9 to
precipitate (40).
X μl sgRNA (IVT; to a ﬁnal concentration of 320 ng/μl; corresponds
to 1:2 ratio SpCas9: sgRNA).
1 μl 10× NEB incubation buffer.
Y μl ddH2O (RNase free) to a total of 10 μl (X + Y = 6.5 μl).
2.5 μl SpCas9 (EnGen Cas9 NLS, NEB #M0646T; 3.22 μg; ﬁnal
concentration 0.8 μg/μl).
Mix gently and incubate the mix at 37°C for 2 min.
Load the mix onto a column (Ultrafree-MC-HV 0.45 μm [Ref:
UFC30HV00]).
Spin for 1 min in a table-top centrifuge @14,000g.
Reincubate the ﬂow-through at 37°C for 2 min.
Let the mix equilibrate at RT for ~30 min before injection. Never
put the mix back on ice.
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Fly genetics
Crosses were done at 25°C. Unless noted otherwise, ﬂy lines were
obtained from the Bloomington Drosophila Stock Center (see the
Acknowledgments section).
Transgenic CIGAR ﬂy lines (integration into ZH-attP 5D [X chro-
mosome] or ZH-attP 102F [fourth chromosome]) were generated by
phiC31 integrase-mediated transgenesis (51, 64). Individual strains
were conﬁrmed to carry the correct shifter sequence by sequencing
the PCR product of the shifter sequence using primers CIGAR-fwd:
CAACAAAGTTGGCGTCGATA and CIGAReGFP-rev: GAACTTCAGGGTCAGCTTGC
(452 bp; for CIGAReGFP); CIGAR-fwd: CAACAAAGTTGGCGTCGATA and
CIGARmCherry-rev: AAGCGCATGAACTCCTTGATG (367 bp; for CIGARmCherry),
respectively. PCR settingswere as follows: 95°C, 5min; 35 cycles of 95°C,
25 s; 60°C, 25 s; and 72°C, 30 s); ﬁnal elongation of 72°C, 10 s. The same
PCR setting was used to analyze the shifter sequence of the CIGAR
reporters by single ﬂy PCR.
The pCFD5-F1 containing U6:3-sgRNACIGAR(1,2) was inserted into
the attP 40 site (#25709; Bloomington).
Fly images
The images were taken on Axio Zoom V16 (Zeiss) and were pro-
cessed in Adobe Photoshop or Adobe Illustrator.
CRISPR–Cas9–induced recombination on the fourth chromosome
(more detailed description).
To determine if we could also induce CRISPR/Cas9–mediated re-
combination on the fourth chromosome, we ﬁrst generated ﬂies
harboring either a CIGAReGFP or CIGARmCherry construct on the fourth
chromosome at position 102F (51). These animals are referred to as
CIGAReGFP,102F, w+ and CIGARmCherry,102F, w+, respectively. Activation of
the reporters was achieved with the previously used tRNA spaced
sgRNA-1,2 tandem array (U6:3-sgRNACIGAR(1,2)). To test if CRISPR-
Cas9–mediated DSBs also result in recombination, the fourth
chromosome, nos-Cas9/Y; U6:3-sgRNACIGAR(1,2)/+; CIGAReGFP,102F, w+/
CIGARmCherry,102F,w+ G0 males were crossed to yw females (or
nosCas9/+;U6:3-sgRNACIGAR(1,2)/+; CIGAReGFP,102F, w+/CIGARmCherry,102F, w+
G0 females to yw males). The offspring of such crosses were ﬁrst
scored at the larval stage to identify animals with either an acti-
vated CIGAReGFP,102F or CIGARmCherry,102F reporter. This preselection
was made to ascertain that DSBs occurred in both constructs
enhancing the likelihood of detecting recombination events on the
fourth chromosome in case they occur. 17 vials (crosses from 12 G0
males and 5 G0 females) containing GFP and mCherry-positive
larvae were selected for further analysis. A total of 172 y,w+ F1
animals harboring either a CIGAReGFP,102F or CIGARmCherry,102F re-
porter but lacking the sgRNA plasmid U6:pCFD5 (to avoid mosaic
ﬂies) from 13 of these crosses were randomly picked right after
hatching. Single ﬂy PCR of the target as well as part of the ﬂuo-
rophore region for the CIGAR reporters was performed for these 172
animals (Tables S2 and S3). PCR products and readable sequences
were obtained in 156 cases.
For the recombination experiments using the CIGAR transgenes
on chromosome 4, we estimate the recombination frequency to be
26%: 41 recombinants identiﬁed/156 ﬂies analyzed × 100 (see Fig 2C
for numbers).
CRISPR-induced recombination between two phenotypic markers
(TR in Fig 3)
To conﬁrm that indeed recombination between sister chromatids
occurs after CRISPR–Cas9–induced DSBs, we tested if we could
induce recombination between two visible markers that are sep-
arated by about 100 kb (Figs 3A and S3). The markers were
w+-marked CIGARmCherry,102F, w+ at 102F and the recessive viable
mutation svspa-pol (a mutation in the eye-speciﬁc enhancer of the
Drosophila Pax 2 gene) located downstream of the w+ marker near
the tip of chromosome 4 (65). The Cas9 target site was selected in
the 39UTR of the toy gene residing about 18 kb downstream of the
CIGARmCherry,102F, w+ transgene insertion site (Fig S3). The rough-eye
phenotype of svspa-pol is reliably scored (100% penetrance) and is
visible if the mutation is homozygous or over a null allele of sv such
as svΔ122 (Sabarinadh Chilaka, Michael Daube, Erich Frei, and Markus
Noll, in preparation).
yw; CIGARmCherry,102F, w+/Dp(1;4)1021,y+, svspa-pol embryos were
injected with recombinant Cas9 protein complexed with in
vitro–translated sgRNA-3 targeting the 39UTR of the toy gene. From
the eclosing G0 animals, a total of 135 crosses were set up. Either
ﬁve G0 females (29 crosses) or single G0 males (106 crosses) were
crossed with homozygous Dp(1;4)1021,y+, svspa-pol ﬂies. F1 offspring
were either yw; CIGARmCherry,102F, w+/Dp(1;4)1021,y+, svspa-pol (UR-A;
phenotypically w+, y+ sv+) or homozygous Dp(1;4)1021,y+, svspa-pol
animals (UR-B; phenotypicallyw, y+, svspa-pol) (Fig 3E). Recombination
events would be phenotypically distinct (Fig 3E; TR-A or TR-B): TR-A is
yw; CIGARmCherry,102F, w+, svspa-pol/Dp(1;4)1021,y+, svspa-pol and would be
scored as having rough, red eyes (w+, y+ svspa-pol). The second re-
combination event (TR-B) that could occur would be yw; Dp(1;4)1021,y+,
sv+/Dp(1;4)1021,y+, svspa-pol ﬂies having white and smooth eyes (w, y+
sv+). From a total of 8,604 scored F1 animals, 253 putative recombinant
ﬂies were recovered: 216 had rough red eyes (2.5%, from 56 in-
dependent G0 crosses) and 37 animals had white and smooth eyes
(ﬁve independent G0 crosses). Notably, in one cross, 31 w−, y+ sv+
animals were present in one tube corresponding to about 25–30% of
the offspring. 70 of the 253 putative recombinants (we picked mostly
males) were backcrossed to homozygousDp(1;4)1021,y+, svspa-pol ﬂies to
establish stocks. 61 of the 70 putative recombinants were recovered
from independent crosses (56 w+, svspa-pol and 5 w, y+, sv+). 13 of the 70
crosses remained without offspring. Most importantly, from 21 putative
recombinants, we could generate homozygous viable lines. 17 of the 21
lines showed the y, w+, svspa-pol phenotype, whereas four lines were w,
y+, sv+ marking all 21 lines as true recombinants. The remaining 36
putative recombinants were homozygous lethal (for more information
on these 36 lines see “Cas9-induced DSBs may lead to loss of chro-
mosomal structures” below).
We then investigated these animals by PCR speciﬁc for the
CRISPR target site. Sequence analysis revealed that with the ex-
ception of two animals all CRISPR sites were without any indel (i.e.,
had a wild-type sequence; Tables S4 and S5). Interestingly, two
recombinants from the same cross (G0 male) showed the same
CRISPR mark (6-bp deletion). However, they had the complemen-
tary phenotype: Whereas one ﬂy showed the y, w+, svspa-pol
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phenotype, the other was phenotypically w, y+, sv+, indicating that
we may have recovered both chromosomes from the same re-
combination event. A third recombined animal from the same cross
showed no CRISPR mark and thus can be counted as independent
recombination event.
Recombination experiment between two phenotypic markers
(NSR in Fig 4)
To assess if CRISPR–Cas9–induced DSBs in general would enhance
the frequency of recombination away from the Cas9 target site, we
repeated the experiment and assessed the recombination fre-
quency between a y+marker on the short, left arm of chromosome 4
and the w+-marked CIGARmCherry,102F inserted at 102F (see NSR in Fig
4C). To use the same experimental conditions and to exclude that
the addition of active Cas9 would also induce recombination
elsewhere on the fourth chromosome, embryos of the genotype
(yw; CIGARmCherry,102F,w+/Dp(1;4)1021,y+, svspa-pol) were injected with
Cas9 protein complexed with in vitro–translated sgRNA-3. This
again would induce DSBs 39 of toy located distal of CIGARmCherry,102F
but should not have any inﬂuence on the recombination between
the y+ and the w+ markers. G0 animals were this time crossed with
yw animals to be able to score crossover events between the y+ and
the w+ marker (Fig 4D). As expected, F1 animals were phenotypically
either yw+ or y+w because the two markers normally segregate.
However, 11 phenotypically y+,w+ ﬂies were recovered from a total of
13,220 analyzed offspring. To assess if the y+,w+ recovered animals
were indeed spontaneous recombinants, or represented non-
disjunction events (i.e., triplo-4 animals which are viable), we
backcrossed such animals again against yw ﬂies. Spontaneous
recombination between y+ and w+ could be excluded as the above-
mentioned backcross would have only revealed phenotypically
y+w+ or yw ﬂies. Instead, nondisjunction could be conﬁrmed in all 11
cases because the backcross revealed phenotypically y+w+, yw, y+w,
and yw+ ﬂies. We determined the non-disjunction rate for the fourth
chromosome to be 1 in 1,200, which is similar to the one observed
for the X chromosome (66).
Supplementary Information
Supplementary Information is available at https://doi.org/10.26508/lsa.
201800267.
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